DrugPatentWatch Database Preview
CLINICAL TRIALS PROFILE FOR NICOTINE
Clinical Trials for Nicotine
Trial ID | Title | Status | Sponsor | Phase | Summary |
---|---|---|---|---|---|
NCT00000284 | Role of Metabolites in Nicotine Dependence (1) - 1 | Completed | University of Minnesota - Clinical and Translational Science Institute | Phase 2 | The purpose of this study is to determine the effects of cotinine with or without a transdermal nicotine replacement on tobacco withdrawal symptoms. |
NCT00000284 | Role of Metabolites in Nicotine Dependence (1) - 1 | Completed | National Institute on Drug Abuse (NIDA) | Phase 2 | The purpose of this study is to determine the effects of cotinine with or without a transdermal nicotine replacement on tobacco withdrawal symptoms. |
NCT00000288 | Role of Metabolites in Nicotine Dependence (2) - 5 | Completed | University of Minnesota - Clinical and Translational Science Institute | Phase 2 | The purpose of this study is to determine the effects of varying doses of cotinine on cigarette self-administration. |
NCT00000288 | Role of Metabolites in Nicotine Dependence (2) - 5 | Completed | National Institute on Drug Abuse (NIDA) | Phase 2 | The purpose of this study is to determine the effects of varying doses of cotinine on cigarette self-administration. |
NCT00000289 | Role of Metabolites in Nicotine Dependence (3) - 6 | Completed | University of Minnesota - Clinical and Translational Science Institute | Phase 2 | The purpose of this study is to determine the effects of various doses of ondansetron transdermal nicotine replacement on tobacco withdrawal symptoms. |
NCT00000289 | Role of Metabolites in Nicotine Dependence (3) - 6 | Completed | National Institute on Drug Abuse (NIDA) | Phase 2 | The purpose of this study is to determine the effects of various doses of ondansetron transdermal nicotine replacement on tobacco withdrawal symptoms. |
NCT00000295 | Progesterone Treatment in Female Smokers - 12 | Completed | University of Minnesota - Clinical and Translational Science Institute | Phase 2 | The purpose of this study is to investigate progesterone effects in female smokers |
Trial ID | Title | Status | Sponsor | Phase | Summary |
Clinical Trial Conditions for Nicotine
Condition Name
Clinical Trial Locations for Nicotine
Trials by Country
Clinical Trial Progress for Nicotine
Clinical Trial Phase
Clinical Trial Status
Clinical Trial Sponsors for Nicotine
Sponsor Name